Company: LCTX
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0000950170-25-070378
Chunk: 0

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Item 1
Chunk 0
---
LINEAGE CELL THERAPEUTICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS)

(UNAUDITED)

     March 31, 2025

     December 31, 2024

     ASSETS

     CURRENT ASSETS

     Cash and cash equivalents
      
     $
     47,886

     $
     45,789

     Marketable securities

     19

     2,016

     Accounts receivable

     213

     638

     Prepaid expenses and other current assets

     1,866

     2,554

     Total current assets

     49,984

     50,997

     NONCURRENT ASSETS

     Property and equipment, net

     2,149

     2,251

     Operating lease right-of-use assets

     1,904

     2,144

     Deposits and other long-term assets

     504

     614

     Goodwill

     10,672

     10,672

     Intangible assets, net

     46,540

     46,540

     TOTAL ASSETS
      
     $
     111,753

     $
     113,218

     LIABILITIES AND SHAREHOLDERS’ EQUITY

     CURRENT LIABILITIES

     Accounts payable and accrued liabilities
      
     $
     4,978

     $
     5,437

     Operating lease liabilities, current portion

     1,124

     1,097

     Finance lease liabilities, current portion

     56

     55

     Deferred revenues, current portion

     6,931

     7,388

     Total current liabilities

     13,089

     13,977

     LONG-TERM LIABILITIES

     Deferred tax liability

     273

     273

     Deferred revenues, net of current portion

     13,611

     14,433

     Operating lease liabilities, net of current portion

     1,013

     1,295

     Finance lease liabilities, net of current portion

     51

     67

     Warrant liabilities

     6,061

     6,161

     TOTAL LIABILITIES

     34,098

     36,206

     Commit